Contact this trialFirst, we need to learn more about you.
Anti-tumor antibiotic
Liposome-encapsulated Daunorubicin-Cytarabine for Acute Myeloid Leukemia
Recruiting1 awardPhase 2
Seattle, Washington
This trial is studying the effect of CPX-351 followed by donor stem cell transplantation compared to immediate donor stem cell transplantation in treating patients with high-grade myeloid cancers that still have some measureable disease.
Fill-in a few details and create your profileHaving a profile will help us send you recommended trials and speed up your application in the future.
We will keep your details privateWe won’t share unless you give us permission. By completing this form you agree to our privacy policy
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.